Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
KY-226 (1 μM
ErSO is a selective anticipatory unfolded protein response (a-UPR) activator
It was approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery
Prunetin 5-O-β-D-glucopyranoside can be used for the research of type-2 diabetes
Pralsetinib (BLU-667) potently inhibits growth of NSCLC and thyroid cancer xenografts driven by various RET mutations and fusions without inhibiting vascular endothelial growth factor receptor 2 (VEGFR-2)
Mirtazapine-d3 N-Oxide dene-2-ethanamine-d9 hydrobromide KY-226 (1 μMProduct information CAS Number: 1219155 54 0 Molecular Weight: 284. 37 Formula: C17H19N3O Chemical Name: 5 (H)methyl 2,5,19 triazatetracyclo[13. 4. 0. 0,. 0,]nonadeca 1(19),8,10,12,15,17 hexaen 5 ium 5 olate Smiles: [2H]C([2H])([2H])[N+]1([O ])CC2C3=CC=CC=C3CC3=CC=CN=C3N2CC1 InChiKey: GAFCUVMEBFTFQJ FIBGUPNXSA N InChi: InChI=1S C17H19N3O c1 20(21)10 9 19 16(12 20)15 7 3 2 5 13(15)11 14 6 4 8 18 17(14)19 h2 8,16H,9 12H2,1H3 i1D3 Technical Data
US$ 23.00
US$ 100.00
US$ 68.00
US$ 84.00
US$ 850.00
US$ 550.00
US$ 185.00
US$ 1100.00